Anika Therapeutics (ANIK) Cash from Operations Growth (3y) (2014 - 2026)
Anika Therapeutics (ANIK) Cash from Operations Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 34.90% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -9.94% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 7.32% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 46.81% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 27.85% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -98.15% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.87% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 111.22% |
| 10 | Anika Therapeutics | 200.80 Mn | 134.01 Mn | 19.00 Mn | -10.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.23% |
| Dec 31, 2025 | 112.83% |
| Sep 30, 2025 | 36.37% |
| Jun 30, 2025 | -27.26% |
| Mar 31, 2025 | 58.87% |
| Dec 31, 2024 | -29.28% |
| Sep 30, 2024 | 34.49% |
| Jun 30, 2024 | -31.02% |
| Mar 31, 2024 | 62.72% |
| Dec 31, 2023 | 12.04% |
| Sep 30, 2023 | 3.41% |
| Jun 30, 2023 | -62.92% |
| Mar 31, 2023 | -76.11% |
| Dec 31, 2022 | -66.70% |
| Sep 30, 2022 | -35.40% |
| Jun 30, 2022 | -17.35% |
| Mar 31, 2022 | -30.47% |
| Dec 31, 2021 | -23.56% |
| Sep 30, 2021 | -42.49% |
| Jun 30, 2021 | -1.34% |